Growth Momentum Recent seed funding of eighty million dollars led by DCVC signals rapid scale for Proxima in AI driven proximity based therapeutics, creating a strong opportunity to engage as a strategic partner for AI compute, data platforms and CRO-enabled workflows.

AI Therapeutics Opportunity Proxima's focus on AI driven drug discovery and proximity based therapeutics opens doors to advanced data analytics, machine learning pipelines, and workflow integrations, making it a good candidate for partners offering cloud compute, AI solutions, and research workflow tools.

Enterprise Fit Located in New York with a mid sized team, Proxima represents a compelling target for enterprise grade software and services, including secure collaboration, scalable data management, regulatory compliant workflows, and multi team deployment across research groups.

Web and Security The current tech stack shows standard web hosting with security best practices; there is an opportunity to help modernize infrastructure with secure cloud deployment, API management, DevOps pipelines, and OpenResty optimization to support rapid experimentation.

Ecosystem Synergy Positioning alongside analytics and AI service peers, Proxima can benefit from partnerships with data analytics firms and CRO networks to accelerate discovery and expand go to market, including co selling and platform integrations.